Kevin C. Conlon

gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma

Douglas J. Schwartzentruber, David H. Lawson, Jon Richards et al. · New England Journal of Medicine · 2011 · 878 citations

Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer

Kevin C. Conlon, Enrico Lugli, Hugh C. Welles et al. · Journal of Clinical Oncology · 2014 · 686 citations · Full text

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

Kevin C. Conlon, Walter J. Urba, John W. Smithii et al. · Cancer · 1990 · 297 citations

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia

Sarah Cooley, Fiona He, Veronika Bachanová et al. · Blood Advances · 2019 · 226 citations · Full text

A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors

Jeffrey S. Miller, Chihiro Morishima, Douglas G. McNeel et al. · Clinical Cancer Research · 2017 · 193 citations · Full text